Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Sorrento Announces Drilling Contract & Receives Permit to Drill Bottom Brook Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News CERo Therapeutics Holdings Inc (QB) CERO

Healthcare Biotechnology
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California. see more

Current News (OTCQB:CERO)

CERo Therapeutics Provides Clinical Update on Phase 1 Trial of CER-1236 in AML (CertainT-1) Highlighting Key Safety Data and Platelet Transfusion-Free Interval Observed in a Patient with Myelodysplastic Syndrome/AML

GlobeNewswire 8 days ago

CERo Therapeutics Provides Clinical Update on Phase 1 Clinical Trial of CER-1236 in AML (CertainT-1)

GlobeNewswire December 17, 2025

CERo Therapeutics Announces Trading on OTCQB Market

GlobeNewswire December 2, 2025

CERo Therapeutics Initiates Second Cohort of Phase 1 Clinical Trial of CER-1236 in AML with Patient Receiving Significant Increase in Dosing

GlobeNewswire November 5, 2025

CERo Therapeutics to Present Data at the Society for Immunotherapy of Cancer Conference Highlighting Lead Compound CER-1236 Sustained Cell Expansion and Cytokine Response

GlobeNewswire November 4, 2025

CERo Therapeutics Announces Listing on OTC Markets

GlobeNewswire November 3, 2025

CERo Therapeutics Announces Receipt of Nasdaq Panel Determination

GlobeNewswire October 29, 2025

CERo Therapeutics Announces Third Dose for Patient in Phase 1 Clinical Trial of CER-1236 in AML

GlobeNewswire October 21, 2025

CERo Therapeutics to Participate in Stem Cell Therapy Panel at the Maxim Growth Summit 2025

GlobeNewswire October 15, 2025
View More News ››

Opinion & Analysis (OTCQB:CERO)

No current opinion is available.
View More Opinion ››

Bullboard Posts (OTCQB:CERO)

CERO...popping r.n

Trading at $7.80.....that's the "breakeven price" for the RS This could really take off On Watch
Iseneschal - July 31, 2025

CERO....last at $7.65

Vols are still low....Cheers !
Iseneschal - July 31, 2025

CERO....I think this is going to get "pumped" ..big time ; )

JMHO....do your own DD...check EDGAR $7.41 bid r.n ; )
Iseneschal - July 31, 2025

CERO....NR this a.m...$7.30....ON watch !!!

CERo Therapeutics Doses Second Acute Myeloid Leukemia Patient with CER-1236 2025-07-31 05:10 PT - News Release ...
Iseneschal - July 31, 2025

CERO....Yeeha ! Halted again at $26.80

Cheers to the Bulls
Iseneschal - June 17, 2025

CERO....17 bones now ; )

Huge !!!!
Iseneschal - June 17, 2025
View more Bullboard ››

Mirasol Resources Ltd.

Mirasol Resources Ltd.

Mirasol Resources Ltd. engages in the acquisition and exploration of mineral properties in Chile and Argentina. The company ...
View More »

Podcasts